Home » Topics » Disease categories and therapies » Immune

Immune
RSS

New JT compounds exert immunostimulating, antiviral and antitumor activity

Sep. 7, 2000

Peptide immunomodulating compounds reported in patent by Cytran

Sep. 6, 2000

Tripedia receives FDA approval for use in the entire DTP immunization series

Sep. 6, 2000

New compounds interacting with CB2 receptors described by Japan Tobacco

Sep. 1, 2000

BioSante signs license option with Antex Biologics for vaccine technology

Sep. 1, 2000

Avant Immunotherapeutics obtains patent license for oral typhoid vaccine

Sep. 1, 2000

Donor intestine irradiation improves survival

Aug. 31, 2000

BioTransplant breeds miniswine without human-tropic PERV

Aug. 31, 2000

BioTransplant reports positive phase I/II results for BTI-322 in liver transplant patients

Aug. 31, 2000

Simulect shows good results in pediatric transplant recipients

Aug. 31, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...